CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors

Volume: 164, Pages: 77 - 91
Published: Feb 1, 2019
Abstract
Cyclin-dependent kinases 8 (CDK8) regulates transcriptional process via associating with the mediator complex or phosphorylating transcription factors (TF). Overexpression of CDK8 has been observed in various cancers. It mediates aberrant activation of Wnt/β-catenin signaling pathway, which is initially recognized and best studied in colorectal cancer (CRC). CDK8 acts as an oncogene and represents a potential target for developing novel CDK8...
Paper Details
Title
CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
Published Date
Feb 1, 2019
Volume
164
Pages
77 - 91
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.